An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients

An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients

Nobuhiro Goi,1 Fumino Iwata,2 Yoko Sugihara,3 Shingo Higa,1 Taiichiro Chikama4 1Medical Affairs, Viatris Pharmaceuticals Japan G.K., Tokyo, Japan; 2Iwata Eye Clinic, 2-15-21 Nishinakanobu, Shinagawa-ku, Tokyo, 142-0054, Japan; 3Global Clinical Operations, Viatris Pharmaceuticals Japan G.K., Tokyo, J...

Full description

Saved in:
Bibliographic Details
Main Authors: Goi N, Iwata F, Sugihara Y, Higa S, Chikama T
Format: Article
Language:English
Published: Dove Medical Press 2024-11-01
Series:Clinical Ophthalmology
Subjects:
cystine
clinical trial
corneal crystals
ivcm total score
photophobia
japan
Online Access:https://www.dovepress.com/an-open-label-phase-iii-study-to-assess-the-efficacy-and-safety-of-cys-peer-reviewed-fulltext-article-OPTH
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/an-open-label-phase-iii-study-to-assess-the-efficacy-and-safety-of-cys-peer-reviewed-fulltext-article-OPTH

Similar Items